Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Canopy Growth

Biotech & Life Sciences · Smiths Falls, Canada · Founded 2014 · IPO 2014 Unicorn

World-leading diversified cannabis company

Valuation
$383M
Market cap · May/2026
Revenue
$197M
Latest reported FY

Investors

1 investor on Canopy Growth's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage
Constellation Brands

Global footprint

Where Canopy Growth has talent and traffic

AI talent share
0.3% of workforce is AI talent
(2 of 697 staff)
Core AI00%
Other AI20.29%
Non-AI workforce69599.71%
Workforce by country
11 countries with
team presence
🇨🇦 Canada85.8%
🇺🇸 United States7%
🇩🇪 Germany3.1%
🇦🇺 Australia1.8%
🇵🇱 Poland0.6%
Top 5 of 11 shown

Patent intelligence

$9M patent portfolio · 37 active families

Estimated portfolio value
$9M
2.5% of market cap · 19.6× smaller than top peer PTC Therapeutics ($184M)
37 active patent families
Where Canopy Growth innovates PharmacologyOrganic chemistryMedicinal chemistryTerpeneCannabis

Where Canopy Growth concentrates vs peers

Each axis is a top-10 topic across Canopy Growth and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Canopy Growth's 15 investments and acquisitions.

Every disclosed deal where Canopy Growth appeared as a backer or acquirer, 2016–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

15 deals across Canopy Growth's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Canopy Growth deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Canopy Growth's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        15 of 15 deals

        Market sentiment

        What the market is saying about Canopy Growth

        An AI-synthesized read of the highest-engagement posts about Canopy Growth on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Canopy Growth on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.